COR Cencora, Inc. Common Stock
O Cencora, Inc. Common Stock Przegląd firmy z Wikipedii
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Czytaj więcej
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
COR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
COR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 15 maja 2026 | $0,6000 |
| 13 lutego 2026 | $0,6000 |
| 14 listopada 2025 | $0,6000 |
| 15 sierpnia 2025 | $0,5500 |
| 16 maja 2025 | $0,5500 |
| 14 lutego 2025 | $0,5500 |
| 15 listopada 2024 | $0,5500 |
| 9 sierpnia 2024 | $0,5100 |
| 9 maja 2024 | $0,5100 |
| 8 lutego 2024 | $0,5100 |
| 10 listopada 2023 | $0,5100 |
| 10 sierpnia 2023 | $0,4850 |
| 11 maja 2023 | $0,4850 |
| 9 lutego 2023 | $0,4850 |
| 10 listopada 2022 | $0,4850 |
| 12 sierpnia 2022 | $0,4600 |
| 13 maja 2022 | $0,4600 |
| 11 lutego 2022 | $0,4600 |
| 1 grudnia 2021 | $1,2700 |
| 12 listopada 2021 | $0,4600 |
COR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 5 25,0%
- Kup 10 50,0%
- Trzymaj 5 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
12 analityków · 2026-08-13Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 września 2026 | $4.48 | $4.39 | 0.09% |
| 30 czerwca 2026 | $4.48 | $4.39 | 0.09% |
| 31 marca 2026 | $4.75 | $4.86 | -0.11% |
| 31 grudnia 2025 | $4.08 | $4.08 | 0.00% |
| 30 września 2025 | $3.84 | $3.82 | 0.02% |
| 30 czerwca 2025 | $4.00 | $3.88 | 0.12% |
| 31 marca 2025 | $4.42 | $4.15 | 0.27% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Bilans 29
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Stopy Wzrostu 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Bilans 27
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Przepływy pieniężne 17
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Rentowność 8
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Efektywność 3
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Przychody | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Marża Brutto % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Marża Operacyjna % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Zysk netto | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| Rozwodniony EPS | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Bilans
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Wskaźnik bieżący | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Wskaźnik Szybkości | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Przepływy pieniężne
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- IYK, MCK, CTVA, COR: ETF Outflow Alert
- Piątek 29/5 Raport o zakupach akcji przez osoby z wewnątrz firmy: SCHW, COR
- Cencora (COR) Wyłania się jako Lider Opieki Zdrowotnej z Solidnymi Fundamentami i Strategiczną Ponowną Wyceną
- Podsumowanie rozmowy o wynikach Cencora za drugi kwartał
- Cencora Inc Konferencja Wynikowa Q2 26 8:30 czasu wschodniego
- Co należy wiedzieć przed publikacją wyników Cencora
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 489 emitentów · $31.4B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 102 (-56 vs poprzedni kw.) | 172 (+41 vs poprzedni kw.) | 434 (-101 vs poprzedni kw.) | 595 (+65 vs poprzedni kw.) | +8.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3 502 993 290 | 12 378 943 | 11,15% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 719 934 713 | 9 611 756 | 8,66% | Akcje |
| STATE STREET CORP | $2 624 351 709 | 9 273 983 | 8,35% | Akcje |
| Walgreens Boots Alliance, Inc. | $2 240 779 050 | 7 473 000 | 7,13% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 358 112 555 | 4 819 419 | 4,32% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $1 231 165 897 | 4 350 717 | 3,92% | Akcje |
| FMR LLC | $850 228 724 | 3 004 554 | 2,71% | Akcje |
| NORGES BANK | $700 042 999 | 2 473 825 | 2,23% | Akcje |
| Capital Research Global Investors | $560 283 987 | 1 979 942 | 1,78% | Akcje |
| Carmignac Gestion | $494 462 712 | 1 747 363 | 1,57% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483 772 138 | 1 709 563 | 1,54% | Akcje |
| Mawer Investment Management Ltd. | $421 312 792 | 1 488 843 | 1,34% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $410 282 013 | 1 449 862 | 1,31% | Akcje |
| CITADEL ADVISORS LLC | $347 541 038 | 1 228 147 | 1,11% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $338 738 459 | 1 197 038 | 1,08% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $315 929 430 | 1 116 828 | 1,01% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313 668 332 | 1 108 447 | 1,00% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $313 605 793 | 1 108 226 | 1,00% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294 327 781 | 1 040 101 | 0,94% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $293 610 144 | 1 037 565 | 0,93% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $268 966 547 | 950 479 | 0,86% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $261 088 180 | 922 638 | 0,83% | Akcje |
| Caisse de depot et placement du Quebec | $258 709 937 | 914 234 | 0,82% | Akcje |
| Boston Partners | $231 295 970 | 817 358 | 0,74% | Akcje |
| National Pension Service | $208 758 025 | 737 713 | 0,66% | Akcje |
| GOLDMAN SACHS GROUP INC | $208 660 680 | 737 369 | 0,66% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $205 281 694 | 653 472 | 0,65% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $180 668 066 | 644 564 | 0,58% | Akcje |
| Burgundy Asset Management Ltd. | $174 893 972 | 599 753 | 0,56% | Akcje |
| Balyasny Asset Management L.P. | $172 225 024 | 608 612 | 0,55% | Akcje |
| Point72 Asset Management, L.P. | $171 131 023 | 604 746 | 0,54% | Akcje |
| Assenagon Asset Management S.A. | $166 084 924 | 586 914 | 0,53% | Akcje |
| Squarepoint Ops LLC | $154 024 599 | 544 295 | 0,49% | Akcje |
| Swiss National Bank | $147 506 155 | 521 260 | 0,47% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $141 101 751 | 498 628 | 0,45% | Akcje |
| Swedbank AB | $134 859 213 | 476 568 | 0,43% | Akcje |
| TimesSquare Capital Management, LLC | $132 589 070 | 422 070 | 0,42% | Akcje |
| Legal & General Group Plc | $129 674 734 | 458 247 | 0,41% | Akcje |
| RHUMBLINE ADVISERS | $123 138 883 | 435 151 | 0,39% | Akcje |
| Vanguard Global Advisers, LLC | $120 449 305 | 425 646 | 0,38% | Akcje |
| BlackRock, Inc. | $119 463 969 | 422 164 | 0,38% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $117 740 633 | 416 074 | 0,37% | Akcje |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113 208 499 | 400 058 | 0,36% | Akcje |
| California Public Employees Retirement System | $110 655 367 | 391 036 | 0,35% | Akcje |
| BANK OF AMERICA CORP /DE/ | $105 342 134 | 372 260 | 0,34% | Akcje |
| SEB Asset Management AB | $104 030 095 | 367 624 | 0,33% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $101 511 435 | 358 723 | 0,32% | Akcje |
| VANGUARD GROUP INC | $100 694 421 | 298 133 | 0,32% | Akcje |
| Walleye Capital LLC | $98 419 595 | 347 797 | 0,31% | Akcje |
| MIZUHO MARKETS AMERICAS LLC | $96 213 200 | 340 000 | 0,31% | Akcje |
| JOHNSON INVESTMENT COUNSEL INC | $93 893 214 | 331 802 | 0,30% | Akcje |
| STOREBRAND ASSET MANAGEMENT AS | $93 049 484 | 328 820 | 0,30% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88 657 847 | 282 224 | 0,28% | Akcje |
| Cornerstone Investment Partners, LLC | $86 260 510 | 304 829 | 0,27% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85 771 238 | 303 100 | 0,27% | Opcja kupna |
| JONES FINANCIAL COMPANIES LLLP | $85 147 559 | 297 583 | 0,27% | Akcje |
| CIBC Private Wealth Group LLC | $83 133 772 | 266 003 | 0,26% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81 593 038 | 288 335 | 0,26% | Akcje |
| FIL Ltd | $79 588 408 | 281 251 | 0,25% | Akcje |
| LPL Financial LLC | $76 804 992 | 271 415 | 0,24% | Akcje |
| TD Asset Management Inc | $76 770 210 | 271 292 | 0,24% | Akcje |
| BANK OF MONTREAL /CAN/ | $70 057 359 | 247 570 | 0,22% | Akcje |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69 812 864 | 246 706 | 0,22% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $68 792 155 | 243 099 | 0,22% | Akcje |
| CITADEL ADVISORS LLC | $68 622 650 | 242 500 | 0,22% | Opcja kupna |
| FIRST MANHATTAN CO. LLC. | $68 126 586 | 240 747 | 0,22% | Akcje |
| AMERIPRISE FINANCIAL INC | $67 675 233 | 239 152 | 0,22% | Akcje |
| TREMBLANT CAPITAL GROUP | $67 203 788 | 237 486 | 0,21% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $64 886 066 | 229 296 | 0,21% | Akcje |
| EARNEST PARTNERS LLC | $63 127 461 | 223 081 | 0,20% | Akcje |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60 624 220 | 214 235 | 0,19% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $60 395 855 | 213 428 | 0,19% | Akcje |
| JENNISON ASSOCIATES LLC | $60 017 829 | 212 092 | 0,19% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59 924 694 | 211 763 | 0,19% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57 032 921 | 201 544 | 0,18% | Akcje |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52 864 060 | 186 812 | 0,17% | Akcje |
| BARCLAYS PLC | $51 304 557 | 181 301 | 0,16% | Akcje |
| Mitsubishi UFJ Trust & Banking Corp | $51 082 984 | 180 518 | 0,16% | Akcje |
| PFA Pension, Forsikringsaktieselskab | $50 217 651 | 177 460 | 0,16% | Akcje |
| MARSHALL WACE, LLP | $50 044 447 | 176 848 | 0,16% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $49 878 621 | 176 262 | 0,16% | Akcje |
| Sio Capital Management, LLC | $49 121 932 | 173 588 | 0,16% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48 634 175 | 162 136 | 0,15% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48 419 177 | 171 284 | 0,15% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47 513 047 | 151 248 | 0,15% | Akcje |
| AVIVA PLC | $47 242 096 | 166 945 | 0,15% | Akcje |
| Jefferies Financial Group Inc. | $46 356 935 | 163 817 | 0,15% | Akcje |
| Brandywine Global Investment Management, LLC | $45 181 831 | 133 773 | 0,14% | Akcje |
| Asset Management One Co., Ltd. | $44 176 566 | 140 627 | 0,14% | Akcje |
| Trajan Wealth LLC | $43 325 888 | 153 106 | 0,14% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43 248 965 | 152 834 | 0,14% | Akcje |
| Ensign Peak Advisors, Inc | $42 869 206 | 151 492 | 0,14% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $42 457 470 | 150 037 | 0,14% | Akcje |
| UBS Group AG | $41 937 353 | 148 199 | 0,13% | Akcje |
| Freestone Grove Partners LP | $41 195 379 | 145 577 | 0,13% | Akcje |
| Qube Research & Technologies Ltd | $40 558 109 | 143 325 | 0,13% | Akcje |
| VAN ECK ASSOCIATES CORP | $40 356 344 | 142 612 | 0,13% | Akcje |
| MACKENZIE FINANCIAL CORP | $40 057 234 | 141 555 | 0,13% | Akcje |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38 839 791 | 137 253 | 0,12% | Akcje |
| ROYAL BANK OF CANADA | $37 959 000 | 134 139 | 0,12% | Akcje |
Insiderzy spółki 49 insiderów · 23 dyrektorzy generalni · 27 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 18 czerwca 2025 M | 44 094 | 0 | 0 | $0 |
| David R Yost | CEO | 17 maja 2011 M | 1 530 341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29 czerwca 2026 A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 9 listopada 2018 M | 53 505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 2 maja 2011 M | 89 698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15 lutego 2007 A | 176 400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 30 czerwca 2026 A | 30 756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 30 czerwca 2026 A | 23 624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16 września 2025 M | 305 913 | 0 | 2 | $-13 314 729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 29 maja 2025 S | 17 154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28 czerwca 2024 A | 9 525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31 maja 2024 S | 13 284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20 grudnia 2021 G | 81 367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21 lutego 2020 M | 6 906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23 maja 2019 S | 1 085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 4 kwietnia 2018 M | 47 989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17 listopada 2017 F | 3 010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 9 listopada 2016 A | 34 195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29 kwietnia 2016 F | 8 897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13 listopada 2015 F | 5 224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13 listopada 2015 M | 4 068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 1 lutego 2010 M | 27 190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27 lutego 2008 A | 25 728 | 0 | 0 | $0 |
| Lauren M Tyler | Dyrektor | 31 lipca 2026 A | 4 456 | 1 | 0 | $148 626 |
| Dennis M Nally | Dyrektor | 31 lipca 2026 A | 13 188 | 0 | 0 | $0 |
| Ellen Cooper | Dyrektor | 31 lipca 2026 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Dyrektor | 18 czerwca 2026 P | 31 767 | 2 | 0 | $2 161 800 |
| Lori Ryerkerk | Dyrektor | 1 lipca 2025 A | 516 | 0 | 0 | $0 |
| Werner Baumann | Dyrektor | 1 maja 2025 A | 2 896 | 0 | 0 | $0 |
| Redonda Miller | Dyrektor | 6 marca 2025 A | 3 194 | 0 | 0 | $0 |
| Frank Clyburn | Dyrektor | 6 marca 2025 A | 1 157 | 0 | 0 | $0 |
| Lorence H. Kim | Dyrektor | 6 marca 2025 A | 3 524 | 0 | 0 | $0 |
| Richard W Gochnauer | Dyrektor | 11 marca 2024 M | 28 762 | 0 | 0 | $0 |
| Kathleen W Hyle | Dyrektor | 11 marca 2024 M | 24 406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Dyrektor | 9 marca 2023 A | 20 479 | 0 | 0 | $0 |
| Jane E Henney MD | Dyrektor | 5 marca 2023 M | 24 685 | 0 | 0 | $0 |
| Michael J Long | Dyrektor | 5 marca 2023 M | 17 724 | 0 | 0 | $0 |
| Douglas R Conant | Dyrektor | 4 marca 2019 M | 8 062 | 0 | 0 | $0 |
| Richard C Gozon | Dyrektor | 29 lutego 2016 M | 51 484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Dyrektor | 2 marca 2015 M | 3 351 | 0 | 0 | $0 |
| Charles H Cotros | Dyrektor | 7 grudnia 2012 M | 26 773 | 0 | 0 | $0 |
| Lawrence J Wilson | Dyrektor | 1 maja 2009 A | 35 942 | 0 | 0 | $0 |
| Rodney H Brady | Dyrektor | 19 lutego 2007 A | 52 746 | 0 | 0 | $0 |
| James R Mellor | Dyrektor | 3 stycznia 2006 M | 32 246 | 0 | 0 | $0 |
| Robert E Martini | Dyrektor | 23 stycznia 2004 G | 1 602 739 | 0 | 0 | $0 |
| Francis G Rodgers | Dyrektor | 3 listopada 2003 A | 7 918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | Posiadacz 10% | 31 lipca 2007 J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 11 marca 2026 M | 160 357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 5 marca 2026 A | 18 408 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 zgłoszenia | 9 czerwca 2025 | 4,96% | Aneks | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23 stycznia 2015 | — | Pierwotne zgłoszenie | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 zgłoszenia | 16 stycznia 2015 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 212 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3,11% | 1 841 NS | 30 kwietnia 2026 | N-PORT |
| IYK · iShares Trust | 2,76% | 121 004 SH | 8 sierpnia 2026 | Dziennie |
| FXG · First Trust Exchange-Traded AlphaDE… | 2,40% | 19 060 NS | 30 kwietnia 2026 | N-PORT |
| PAWZ · ProShares Trust | 2,36% | 2 847 NS | 31 maja 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,34% | 1 750 NS | 31 maja 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,26% | 12 908 SH | 8 sierpnia 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 2,16% | 1 935 NS | 30 kwietnia 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,91% | 186 NS | 30 kwietnia 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,83% | 568 607 SH | 8 sierpnia 2026 | Dziennie |
| SWP · Manager Directed Portfolios | 1,75% | 10 059 NS | 31 maja 2026 | N-PORT |
| IWP · iShares Trust | 1,73% | 1 079 322 SH | 8 sierpnia 2026 | Dziennie |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 42 128 SH | 8 sierpnia 2026 | Dziennie |
| QIDX · Spinnaker ETF Series | 1,66% | 2 065 NS | 30 kwietnia 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 30 kwietnia 2026 | N-PORT |
| USMV · iShares Trust | 1,29% | 958 985 SH | 8 sierpnia 2026 | Dziennie |
| ESMV · iShares Trust | 1,27% | 308 SH | 8 sierpnia 2026 | Dziennie |
| UPSD · ETF Series Solutions | 1,21% | 3 966 NS | 30 kwietnia 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,17% | 7 354 NS | 30 kwietnia 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,17% | 1 161 NS | 30 kwietnia 2026 | N-PORT |
| ACWV · iShares, Inc. | 1,17% | 120 628 SH | 8 sierpnia 2026 | Dziennie |
| FMAG · FIDELITY COVINGTON TRUST | 1,10% | 9 066 NS | 30 kwietnia 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,10% | 73 945 NS | 30 kwietnia 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,03% | 608 442 NS | 30 kwietnia 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,02% | 1 555 NS | 30 kwietnia 2026 | N-PORT |
| GROZ · Zacks Trust | 0,93% | 3 136 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,92% | 84 961 NS | 30 kwietnia 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1 187 313 SH | 8 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,86% | 3 879 NS | 30 kwietnia 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,85% | 45 117 SH | 8 sierpnia 2026 | Dziennie |
| IMCG · iShares Trust | 0,84% | 105 034 SH | 8 sierpnia 2026 | Dziennie |
| IXJ · iShares Trust | 0,80% | 102 068 SH | 8 sierpnia 2026 | Dziennie |
| ALTL · Pacer Funds Trust | 0,79% | 2 471 NS | 30 kwietnia 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 6 030 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 555 571 SH | 8 sierpnia 2026 | Dziennie |
| PALC · Pacer Funds Trust | 0,76% | 5 696 NS | 30 kwietnia 2026 | N-PORT |
| RXL · ProShares Trust | 0,76% | 2 029 NS | 31 maja 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,75% | 285 NS | 31 maja 2026 | N-PORT |
| ROE · EA Series Trust | 0,73% | 7 012 NS | 29 maja 2026 | N-PORT |
| TAX · EA Series Trust | 0,72% | 680 NS | 29 maja 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,68% | 342 NS | 30 kwietnia 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,68% | 249 048 NS | 30 kwietnia 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,66% | 3 314 NS | 31 maja 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 18 623 SH | 8 sierpnia 2026 | Dziennie |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4 005 623 SH | 8 sierpnia 2026 | Dziennie |
| QARP · DBX ETF Trust | 0,49% | 1 374 NS | 29 maja 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,47% | 2 120 NS | 31 maja 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,44% | 77 004 NS | 30 kwietnia 2026 | N-PORT |
| IWR · iShares Trust | 0,43% | 760 297 SH | 8 sierpnia 2026 | Dziennie |
| IMCB · iShares Trust | 0,43% | 22 227 SH | 8 sierpnia 2026 | Dziennie |
| JSTC · Tidal Trust I | 0,40% | 4 993 NS | 31 maja 2026 | N-PORT |